March 28, 2024 —  Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.

March 27, 2024 — Elixir Medical has announced it has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its DynamX BTK System, a novel, adaptive implant for use in the treatment of narrowed or blocked vessels below-the-knee (BTK) in patients with chronic limb-threatening ischemia (CLTI).

March 27 2024 — HeartFlow, Inc., a leader in AI-driven healthcare technology, announced the launch of the DECIDE Registry, the largest prospective registry of its kind, with the first site initiated, Cone Health Care.

March 27, 2024 — Merck, known as MSD outside of the United States and Canada, announced  that the U.S. Food and Drug Administration (FDA) has approved sotatercept-csrk (U.S.

March 26, 2024 — Medical imaging AI company Avicenna.AI announced that it has received 510(k) clearance from the US Fo

March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II-III obstructive hypertrophic cardiomyopathy at the American College of Cardiology/ACC Annual Scientific Session & Expo, ACC.24, taking place April 6-8, 2024 in Atlanta, Geo

March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with irregular heart rhythms, known as arrhythmias, which can lead to complications like palpitations, fainting and stroke.

Subscribe Now